Adcock Ingram misses out on main ARV tender despite state’s localisation goal


A local pharmaceutical industry body is questioning why almost half of the main medicines in a three-year R11bn antiretroviral (ARV) tender will be bought from Indian companies while SA’s Adcock Ingram was overlooked.

The tender is awarded by the department of health every three years and covers all the ARV drugs used by the state in the world’s largest HIV treatment programme…


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Discover more from Africa Health Report

Subscribe now to keep reading and get access to the full archive.

Continue reading